Physician profile
Ali Sultan-Qurraie
NPI 1114156940
$34,280.01
in general payments reported to CMS, 2019-2025
19 companies · $11K in 2025
The $11K reported for 2025 was more than what 92% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,193 · 2020: $269 · 2021: $5,145 · 2022: $1,536 · 2023: $3,599 · 2024: $10K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $9,540 · Consulting Fee: $4,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,098.34 |
| Food and Beverage | $9,540.14 |
| Consulting Fee | $4,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $10,230.35 | 2019-2025 | Smart Coil, Penumbra System, Penumbra Coil 400 |
| Abbott Laboratories | $9,570.33 | 2021-2025 | Supera, Xact, Perclose Prostyle |
| Microvention, INC. | $4,699.54 | 2021-2025 | Web Aneurysm Embolization System, Stent, Helical Regular 18 Advanced |
| Medtronic, INC. | $2,129.44 | 2021-2025 | Pipeline, Solitaire X |
| Depuy Synthes Sales INC. | $2,002.30 | 2019-2025 | Cerepak Uniform, Trufill, Emboguard |
| Stryker Corporation | $1,821.82 | 2019-2025 | Broadway 8, Target, Surpass Evolve |
| Medical Device Business Services, INC. | $1,492.02 | 2021 | |
| Imperative Care, INC | $749.15 | 2021-2024 | Zoom 88-T Large Distal Platform |
| Medtronic USA, INC. | $433.97 | 2019-2020 | |
| Viz.Ai, INC. | $335.54 | 2022 | |
| Shockwave Medical, INC | $206.69 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $125.00 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $120.45 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $117.58 | 2022 | |
| Amgen INC. | $111.11 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $73.79 | 2025 | Mynx Control Venous, Mynx Control |
| Balt USA, LLC | $31.47 | 2025 | Ballast 088 Long Sheath |
| Astrazeneca Pharmaceuticals Lp | $15.00 | 2023 | Brilinta |
| Qapel Medical INC | $14.46 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Sultan-Qurraie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.